| pubmed-article:6433216 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6433216 | lifeskim:mentions | umls-concept:C0007603 | lld:lifeskim |
| pubmed-article:6433216 | lifeskim:mentions | umls-concept:C0039067 | lld:lifeskim |
| pubmed-article:6433216 | lifeskim:mentions | umls-concept:C1622418 | lld:lifeskim |
| pubmed-article:6433216 | lifeskim:mentions | umls-concept:C1882598 | lld:lifeskim |
| pubmed-article:6433216 | lifeskim:mentions | umls-concept:C1441547 | lld:lifeskim |
| pubmed-article:6433216 | lifeskim:mentions | umls-concept:C1326363 | lld:lifeskim |
| pubmed-article:6433216 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:6433216 | pubmed:dateCreated | 1984-9-25 | lld:pubmed |
| pubmed-article:6433216 | pubmed:abstractText | Transport of beta-alanine has been demonstrated in membrane vesicles isolated from rat brain, using artificially imposed ion gradients as the sole energy source. The uptake of beta-alanine is strictly dependent on the presence of Na+ and Cl- in the medium, and the process can be driven either by an Na+ gradient (out greater than in) or by a Cl- gradient (out greater than in) when the other essential ion is present. The process is stimulated by a membrane potential (negative inside) as demonstrated by the effect of ionophore valinomycin and anions with different permeabilities. beta-Alanine uptake is inhibited by the presence of GABA. | lld:pubmed |
| pubmed-article:6433216 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6433216 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6433216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6433216 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6433216 | pubmed:month | May | lld:pubmed |
| pubmed-article:6433216 | pubmed:issn | 0364-3190 | lld:pubmed |
| pubmed-article:6433216 | pubmed:author | pubmed-author:ValdiviesoFF | lld:pubmed |
| pubmed-article:6433216 | pubmed:author | pubmed-author:GimenezCC | lld:pubmed |
| pubmed-article:6433216 | pubmed:author | pubmed-author:AragonM CMC | lld:pubmed |
| pubmed-article:6433216 | pubmed:author | pubmed-author:ZafraFF | lld:pubmed |
| pubmed-article:6433216 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6433216 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:6433216 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6433216 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6433216 | pubmed:pagination | 695-707 | lld:pubmed |
| pubmed-article:6433216 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:meshHeading | pubmed-meshheading:6433216-... | lld:pubmed |
| pubmed-article:6433216 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6433216 | pubmed:articleTitle | beta-Alanine transport into plasma membrane vesicles derived from rat brain synaptosomes. | lld:pubmed |
| pubmed-article:6433216 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6433216 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6433216 | lld:pubmed |
